Kate Therapeutics

Kate Therapeutics

Private & Independent

10675 Sorrento Valley Rd 150
San Diego, CA 92121
USA

Undisclosed

Kate Therapeutics is a patient-focused biotechnology company developing AAV-based gene therapies to treat genetically defined muscle and heart diseases. We are based in San Diego, California. Kate Therapeutics is applying novel technology platforms that directly address the key limitations of current gene therapies, including tissue-specific delivery and gene regulation. These breakthroughs have the potential to improve the efficacy and safety of gene therapy and enable the pursuit of a broader set of disease targets that are otherwise difficult to drug with current technologies. Data supporting one of our approaches to improve AAV-mediated gene delivery has been published (Tabebordbar et al., Cell, 2021). Our novel capsids provide superior muscle and heart transduction and liver de-targeting compared to the naturally occurring serotypes currently used in clinical trials. This may enable more complete tissue transduction at significantly lower and safer doses, addressing a major limita

6/8/2023